Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Moderna Inc’s current trading price is -81.53% away from its 52-week high, while its distance from the 52-week low is 4.12%. The stock’s price range during this period has varied between $30.24 and $170.47. The company, active in the Healthcare sector, saw a trading volume of around 10.48 million for the day, considerably lower average daily volume of 10.61 million observed over the last three months.
Moderna Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $170.47 on 05/24/24, and the lowest price during that time was $30.24, recorded on 02/14/25.
How Financial Performance Impacts Market Capitalization
Moderna Inc (MRNA) has experienced a quarterly decline of -27.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.12B and boasts a workforce of 5600 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 45.75, with a change in price of -33.28. Similarly, Moderna Inc recorded 8,812,942 in trading volume during the last 100 days, posting a change of -50.66%.
How MRNA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.11.
MRNA Stock Stochastic Average
As of today, the raw stochastic average of Moderna Inc over the past 50 days is 15.49%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 18.90%. Additionally, the Stochastic %K and %D values for the company were 10.64% and 5.73%, respectively, over the past 20 days.
MRNA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -24.27%. However, over the past six months, we’ve seen a stronger performance of -61.72%. The price of MRNA leaped by -9.44% over the last 30 days. And in the last five days, it has fallen by -3.41%.
